UBS Group
MARXR

UBS Group’s Mars Acquisition Corp. Rights MARXR Stock Holding History

UBS Group’s Portfolio MARXR Stock Details MARXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-95
Closed -$18 – 10526
2024
Q2 		$18 Buy
+95
New +$21 ﹤0.01% 9319

Other funds holding MARXR

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

UBS Group's MARXR Position: Q3 2024 in Review

UBS Group sold out of Mars Acquisition Corp. Rights (MARXR) in Q3 2024, closing a stake of 95 shares — an estimated $18 sold.

UBS Group first reported a position in MARXR in Q2 2024 and held it in 1 quarter. The position peaked at $18 in Q2 2024. 27 funds tracked by Wall St. Rank hold MARXR as of Q3 2024.

  • UBS Group reported no remaining Mars Acquisition Corp. Rights position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 95 Mars Acquisition Corp. Rights shares in Q3 2024, an estimated $18.
  • UBS Group first reported a position in Mars Acquisition Corp. Rights in Q2 2024 and held it in 1 quarter.
  • UBS Group's Mars Acquisition Corp. Rights position peaked at $18 in Q2 2024.
  • 27 funds tracked by Wall St. Rank held Mars Acquisition Corp. Rights as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.